Form 4 for CODX Co-Diagnostics, Inc.
Accepted 2022-01-10 00:00:00 ET · period of report 2022-01-08 · accession 0001562180-22-000370 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-10 | 2022-01-08 | CODX | NELSON JAMES B | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
| D | 2022-01-10 | 2022-01-08 | CODX | NELSON JAMES B | Dir | M - OptEx | $0.00 | -12.5K | 12.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-08 | A | A | 12,500 | $0.00 | 12,500 | D | — | — | (F1) Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. |
| 2 | Derivative | Restricted Stock Units | 2022-01-08 | M | D | 12,500 | $0.00 | 12,500 | D | $0.00 · — to — | 25,000 Common Stock | (F1) Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. |